Plastic Hat Trial to Prevent Hypothermia in Preterm Newborns in the Delivery Room
NCT ID: NCT00904228
Last Updated: 2019-04-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
260 participants
INTERVENTIONAL
2008-09-30
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Heat Loss Prevention in Delivery Room Using a Polyethylene Cap
NCT00930917
Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part I
NCT01604317
Neonatal Warming to Prevent Hypothermia
NCT04827394
Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part II
NCT01604421
Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part V
NCT01604460
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Randomization of the neonates will be carried out in the delivery room by opening a sealed, opaque envelope just prior to birth. Qualified preterm newborns will be stratified into 2 OB EGA groups: (≤28weeks obstetrical(OB)estimated gestational age (EGA) and 29-32weeks OB EGA. In each stratified group, the newborns will be further randomized to control arm (stockinet head covering) or the intervention arm (plastic-lined head covering). Each arm of the study will have a sample size of 65, allowing for 130 infants in each OB EGA stratified group and for a sample size total of 260. Treatment versus control will be assigned by blocks of 8 by using a random permutation table. The assignment will be sealed in an opaque envelope by a non-participant person of the research.
The PMH high-risk resuscitation (RESUS) team attends all deliveries of infants ≤32 weeks OB EGA. The RESUS team is comprised of a resuscitation nurse, a respiratory therapist, and a practitioner. Neonatology fellow and/or attending may also attend these deliveries.
The use of warming aids by the RESUS team is standardized in the following manner: Randomization envelope will be opened. All infants will be taken from the obstetrician by the practitioner to an Ohio radiant warmer that has been pre-warmed to 100% capacity prior to the delivery of the infant. A food-grade storage (polyethylene) bag (will be referred as "poncho") will be used on all infants with the EGA of 32 weeks or less OB EGA to decrease evaporative and convective heat loss. The poncho will be placed by cutting a hole at the closed end of the bag for the purposes of inserting the head through it. The infants will not be dried except for the face as recommended by NRP. All infants that are ≤28weeks OB EGA will have a transwarmer mattress gel pad activated and placed on the radiant warmer during resuscitation and during transport as per PMH NICU and NRP standard practice. The appropriate head covering will then be placed to the level of the forehead on the infant as per randomization assignment. If access to the infant's umbilical cord is needed, a hole will be cut at the appropriate location. All infants will be transported in a dedicated isolette for resuscitation that has been prewarmed to 38ºC. The warming aids will be in place until the infant's arrival in the NICU.
The RESUS team will gather the following data in the delivery room: environmental temperature of the delivery room, rectal temperature immediately after delivery, annotation of warming aids implemented. The RESUS team also cares for the infant in the first 4 hours of life. Initial vital signs (heart rate, respiratory rate, and blood pressure), temperature, need of ventilation, need of intervention will be recorded by the RESUS team. After 4 hours the care will be assumed by the primary NICU team as per our standard practice.
Once the admission rectal temperature is taken, the head coverings will be removed and the infant will no longer be actively enrolled in the research. The rest of the data will be gathered through the Neonatal Resuscitation Database and Parkland NICU Morbidity and Mortality Database.
The rationale of this study is that no randomized control trial has been done to demonstrate the effectiveness of placement of plastic-lined head covering versus stockinet head covering. It would seem logical that if measures are taken to decrease heat loss from the head, these measures would improve temperature stability and avoid hypothermia in the premature neonate.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Plastic Cap
Plastic lined stockinet cap (polyethylene bag)
placement of plastic cap during delivery room stabilization
placement of plastic cap during delivery room stabilization
Stockinet Cap
Usual practice
placement of routine cap during delivery room stabilization
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
placement of plastic cap during delivery room stabilization
placement of plastic cap during delivery room stabilization
placement of routine cap during delivery room stabilization
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infants delivered in Parkland Memorial Hospital Labor and Delivery areas
* Infant whose delivery was attended by the Parkland Neonatal Resuscitation Team
* Infant whos is viable
Exclusion Criteria
* Infant who is deemed non-viable
* Infant who did not have the Parkland Neonatal Resuscitation Team present at time of birth
* Infant with congenital anomaly which precludes measurement of rectal temperature (such as anal atresia or imperforate anus)
1 Hour
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Texas Southwestern Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Myra Wyckoff
Professor of Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lilian T StJohn, MD
Role: PRINCIPAL_INVESTIGATOR
University of Texas Southwestern Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Parkland Memorial Hospital
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
052008-049
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.